Find your next paid study

University of Colorado, DenverNCT05287568

~$150 – $3,000

Actual pay is set by the research site.

Mental HealthHealth ServicesEvidence Based Programs in Schools

Beliefs and Attitudes for Successful Implementation in Schools (BASIS) Optimization

The objective of the BASIS R34 pilot study is to test the impact of eBASIS in a randomized controlled trial (RCT). Consistent with IMPACT's IQM, the study test…

University of WashingtonNCT06672835

~$10 – $750

Actual pay is set by the research site.

An Adaptive Two-Part, Phase 1/2, Multi-Center, Double-Blinded, Randomized, Controlled Study of the Safety and Efficacy of Topically Applied PEP-TISSEEL in Participants With Chronic Radiation Ulcer

The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chroni…

Chronic Radiation Ulcer

~$150 – $4,200

Actual pay is set by the research site.

Rion Inc.NCT06793748

Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test res…

Cancer

Abramson Cancer Center at Penn MedicineNCT07471958

~$10 – $750

Actual pay is set by the research site.

Using Shared Decision Making to Improve Family Media Use Planning

Investigators will conduct a pilot randomized controlled trial assessing the efficacy and feasibility of the newly developed Family Media Check-In (FMC).

Adolescent Behavior

Seattle Children's HospitalNCT05722535

~$10 – $750

Actual pay is set by the research site.

Breast Ductal Carcinoma In Situ

A Phase IB Trial of Neoadjuvant Multi-Epitope HER2 Peptide Vaccine in Patients With HER2-Expressing DCIS

This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma…

~$150 – $3,000

Actual pay is set by the research site.

Mayo ClinicNCT04144023

Gastroesophageal Adenocarcinoma

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) - a Phase Ib Feasibility Trial

This is a phase 1b prospective, single arm, open-label trial determining the efficacy and feasibility of using a response-guided approach to help guide neoadju…

University of California, IrvineNCT05733689

~$150 – $3,000

Actual pay is set by the research site.

ALS (Amyotrophic Lateral Sclerosis)TBI Traumatic Brain InjurySCI - Spinal Cord Injury+1 more

Cognixion Pass Through Study

The goal of this study is refine the usability of a BCI capable communication platform. The study will take place in the United States area and will enroll up…

~$10 – $1,125

Actual pay is set by the research site.

CognixionNCT07209943

Resectable Localized Prostate Cancer

A Randomized, Placebo Controlled Proof of Principle (Window of Opportunity) Study of Hydroxychloroquine (HCQ) in Prostate Cancer Patients Undergoing Radical Prostatectomy

This is randomized, double blind, placebo controlled proof of principle (window of opportunity) study of oral hydroxychloroquine in patients with resectable lo…

Lionel.D.Lewis, MDNCT06408298

~$150 – $4,500

Actual pay is set by the research site.

Phase 4

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsy…

Alzheimer Disease

University of Texas at AustinNCT03082755

~$25 – $1,000

Actual pay is set by the research site.

Eosinophilic Esophagitis (EoE)

Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis Induction of Remission

This study aims to introduce a new dietary therapy for Eosinophilic Esophagitis (EoE) patients by using partial enteral nutrition (PEN) to enhance remission ra…

Kate Farms IncNCT07234825

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors

To study possible biomarkers that may be related to how SAR444881 works (either alone or when combined with cemiplimab) in participants with solid tumors.

Solid Tumors